JP2014511426A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014511426A5 JP2014511426A5 JP2013557126A JP2013557126A JP2014511426A5 JP 2014511426 A5 JP2014511426 A5 JP 2014511426A5 JP 2013557126 A JP2013557126 A JP 2013557126A JP 2013557126 A JP2013557126 A JP 2013557126A JP 2014511426 A5 JP2014511426 A5 JP 2014511426A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- polymer according
- polymer
- monomer
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229920000642 polymer Polymers 0.000 claims description 26
- 229940079593 drug Drugs 0.000 claims description 11
- 239000003814 drug Substances 0.000 claims description 11
- 239000011159 matrix material Substances 0.000 claims description 2
- 239000000178 monomer Substances 0.000 claims 17
- 229920001223 polyethylene glycol Polymers 0.000 claims 10
- 229920001400 block copolymer Polymers 0.000 claims 7
- 229910052799 carbon Inorganic materials 0.000 claims 7
- 125000004122 cyclic group Chemical group 0.000 claims 6
- -1 t-butylaminoethyl (methyl) acrylate Chemical compound 0.000 claims 6
- 125000004432 carbon atom Chemical group C* 0.000 claims 5
- 229910052739 hydrogen Inorganic materials 0.000 claims 5
- 239000000203 mixture Substances 0.000 claims 5
- 239000004971 Cross linker Substances 0.000 claims 4
- 125000003118 aryl group Chemical group 0.000 claims 4
- 239000007943 implant Substances 0.000 claims 4
- 229920001606 poly(lactic acid-co-glycolic acid) Polymers 0.000 claims 4
- 239000000651 prodrug Substances 0.000 claims 4
- 229940002612 prodrug Drugs 0.000 claims 4
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims 3
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 claims 3
- 125000000217 alkyl group Chemical group 0.000 claims 3
- 239000012986 chain transfer agent Substances 0.000 claims 3
- 239000003431 cross linking reagent Substances 0.000 claims 3
- 125000000524 functional group Chemical group 0.000 claims 3
- 230000000379 polymerizing effect Effects 0.000 claims 3
- 239000012798 spherical particle Substances 0.000 claims 3
- 210000001519 tissue Anatomy 0.000 claims 3
- JIFCOORMJVPBTN-UHFFFAOYSA-N 2-methylidene-1,3,6-trioxocane Chemical compound C=C1OCCOCCO1 JIFCOORMJVPBTN-UHFFFAOYSA-N 0.000 claims 2
- AOJJSUZBOXZQNB-TZSSRYMLSA-N Doxorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-TZSSRYMLSA-N 0.000 claims 2
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 claims 2
- NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 claims 2
- NWIBSHFKIJFRCO-WUDYKRTCSA-N Mytomycin Chemical compound C1N2C(C(C(C)=C(N)C3=O)=O)=C3[C@@H](COC(N)=O)[C@@]2(OC)[C@@H]2[C@H]1N2 NWIBSHFKIJFRCO-WUDYKRTCSA-N 0.000 claims 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims 2
- 238000010521 absorption reaction Methods 0.000 claims 2
- 125000002723 alicyclic group Chemical group 0.000 claims 2
- BLFLLBZGZJTVJG-UHFFFAOYSA-N benzocaine Chemical compound CCOC(=O)C1=CC=C(N)C=C1 BLFLLBZGZJTVJG-UHFFFAOYSA-N 0.000 claims 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 2
- 239000003795 chemical substances by application Substances 0.000 claims 2
- 229960004357 chloramphenicol succinate Drugs 0.000 claims 2
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N coumarin Chemical compound C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 claims 2
- 229920006037 cross link polymer Polymers 0.000 claims 2
- 125000001072 heteroaryl group Chemical group 0.000 claims 2
- 230000002209 hydrophobic effect Effects 0.000 claims 2
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 claims 2
- 125000005647 linker group Chemical group 0.000 claims 2
- 229920001427 mPEG Polymers 0.000 claims 2
- 239000002105 nanoparticle Substances 0.000 claims 2
- 229910052757 nitrogen Inorganic materials 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 238000006116 polymerization reaction Methods 0.000 claims 2
- 231100000241 scar Toxicity 0.000 claims 2
- 230000017423 tissue regeneration Effects 0.000 claims 2
- 230000037303 wrinkles Effects 0.000 claims 2
- 125000003837 (C1-C20) alkyl group Chemical group 0.000 claims 1
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims 1
- 229920002818 (Hydroxyethyl)methacrylate Polymers 0.000 claims 1
- LEBVLXFERQHONN-UHFFFAOYSA-N 1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide Chemical compound CCCCN1CCCCC1C(=O)NC1=C(C)C=CC=C1C LEBVLXFERQHONN-UHFFFAOYSA-N 0.000 claims 1
- LMAUULKNZLEMGN-UHFFFAOYSA-N 1-ethyl-3,5-dimethylbenzene Chemical compound CCC1=CC(C)=CC(C)=C1 LMAUULKNZLEMGN-UHFFFAOYSA-N 0.000 claims 1
- VDNJGYSBTLOSGU-UHFFFAOYSA-N 2-(diethylamino)prop-2-enoic acid Chemical compound CCN(CC)C(=C)C(O)=O VDNJGYSBTLOSGU-UHFFFAOYSA-N 0.000 claims 1
- PWKDHWCKSUMJID-UHFFFAOYSA-N 2-methylidene-1,3-dioxane Chemical compound C=C1OCCCO1 PWKDHWCKSUMJID-UHFFFAOYSA-N 0.000 claims 1
- AVUFZLGLMCACRE-UHFFFAOYSA-N 2-methylidene-1,3-dioxepane Chemical compound C=C1OCCCCO1 AVUFZLGLMCACRE-UHFFFAOYSA-N 0.000 claims 1
- VHMYBWIOLGKSHO-UHFFFAOYSA-N 2-methylidene-1,3-dioxolane Chemical compound C=C1OCCO1 VHMYBWIOLGKSHO-UHFFFAOYSA-N 0.000 claims 1
- FHTWQMHOTBIHEP-UHFFFAOYSA-N 2-methylidene-4-phenyl-1,3-dioxolane Chemical compound O1C(=C)OCC1C1=CC=CC=C1 FHTWQMHOTBIHEP-UHFFFAOYSA-N 0.000 claims 1
- 208000002874 Acne Vulgaris Diseases 0.000 claims 1
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 claims 1
- 208000022211 Arteriovenous Malformations Diseases 0.000 claims 1
- LIRCDOVJWUGTMW-ZWNOBZJWSA-N Chloramphenicol succinate Chemical compound OC(=O)CCC(=O)OC[C@@H](NC(=O)C(Cl)Cl)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 LIRCDOVJWUGTMW-ZWNOBZJWSA-N 0.000 claims 1
- 229920000858 Cyclodextrin Polymers 0.000 claims 1
- GHASVSINZRGABV-UHFFFAOYSA-N Fluorouracil Chemical compound FC1=CNC(=O)NC1=O GHASVSINZRGABV-UHFFFAOYSA-N 0.000 claims 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 claims 1
- 208000032843 Hemorrhage Diseases 0.000 claims 1
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 claims 1
- 206010061218 Inflammation Diseases 0.000 claims 1
- 201000008450 Intracranial aneurysm Diseases 0.000 claims 1
- 239000002147 L01XE04 - Sunitinib Substances 0.000 claims 1
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 claims 1
- 208000018525 Postpartum Hemorrhage Diseases 0.000 claims 1
- 208000037534 Progressive hemifacial atrophy Diseases 0.000 claims 1
- 206010000496 acne Diseases 0.000 claims 1
- 229940035676 analgesics Drugs 0.000 claims 1
- 239000000730 antalgic agent Substances 0.000 claims 1
- 239000003242 anti bacterial agent Substances 0.000 claims 1
- 239000002260 anti-inflammatory agent Substances 0.000 claims 1
- 229940121363 anti-inflammatory agent Drugs 0.000 claims 1
- 229940088710 antibiotic agent Drugs 0.000 claims 1
- 239000002246 antineoplastic agent Substances 0.000 claims 1
- 230000005744 arteriovenous malformation Effects 0.000 claims 1
- 125000004429 atom Chemical group 0.000 claims 1
- PFOLLRNADZZWEX-FFGRCDKISA-N bacampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@@H]3N(C2=O)[C@H](C(S3)(C)C)C(=O)OC(C)OC(=O)OCC)=CC=CC=C1 PFOLLRNADZZWEX-FFGRCDKISA-N 0.000 claims 1
- 229960002699 bacampicillin Drugs 0.000 claims 1
- 229960005274 benzocaine Drugs 0.000 claims 1
- 230000000740 bleeding effect Effects 0.000 claims 1
- 210000004204 blood vessel Anatomy 0.000 claims 1
- 229960003150 bupivacaine Drugs 0.000 claims 1
- 125000004106 butoxy group Chemical group [*]OC([H])([H])C([H])([H])C(C([H])([H])[H])([H])[H] 0.000 claims 1
- CQEYYJKEWSMYFG-UHFFFAOYSA-N butyl acrylate Chemical compound CCCCOC(=O)C=C CQEYYJKEWSMYFG-UHFFFAOYSA-N 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- 238000004113 cell culture Methods 0.000 claims 1
- DQLATGHUWYMOKM-UHFFFAOYSA-L cisplatin Chemical compound N[Pt](N)(Cl)Cl DQLATGHUWYMOKM-UHFFFAOYSA-L 0.000 claims 1
- 229960004316 cisplatin Drugs 0.000 claims 1
- 229960000956 coumarin Drugs 0.000 claims 1
- 235000001671 coumarin Nutrition 0.000 claims 1
- 150000003983 crown ethers Chemical class 0.000 claims 1
- 229940097362 cyclodextrins Drugs 0.000 claims 1
- 229960003957 dexamethasone Drugs 0.000 claims 1
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 claims 1
- 229940039227 diagnostic agent Drugs 0.000 claims 1
- 239000000032 diagnostic agent Substances 0.000 claims 1
- 229960001259 diclofenac Drugs 0.000 claims 1
- DCOPUUMXTXDBNB-UHFFFAOYSA-N diclofenac Chemical compound OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl DCOPUUMXTXDBNB-UHFFFAOYSA-N 0.000 claims 1
- 229960004679 doxorubicin Drugs 0.000 claims 1
- 208000001780 epistaxis Diseases 0.000 claims 1
- 150000002148 esters Chemical class 0.000 claims 1
- DUDCYUDPBRJVLG-UHFFFAOYSA-N ethoxyethane methyl 2-methylprop-2-enoate Chemical compound CCOCC.COC(=O)C(C)=C DUDCYUDPBRJVLG-UHFFFAOYSA-N 0.000 claims 1
- 208000002980 facial hemiatrophy Diseases 0.000 claims 1
- 239000010408 film Substances 0.000 claims 1
- 229960002949 fluorouracil Drugs 0.000 claims 1
- 239000006260 foam Substances 0.000 claims 1
- 208000030304 gastrointestinal bleeding Diseases 0.000 claims 1
- SDUQYLNIPVEERB-QPPQHZFASA-N gemcitabine Chemical compound O=C1N=C(N)C=CN1[C@H]1C(F)(F)[C@H](O)[C@@H](CO)O1 SDUQYLNIPVEERB-QPPQHZFASA-N 0.000 claims 1
- 229960005277 gemcitabine Drugs 0.000 claims 1
- 238000009499 grossing Methods 0.000 claims 1
- 125000005842 heteroatom Chemical group 0.000 claims 1
- 125000001165 hydrophobic group Chemical group 0.000 claims 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 1
- 229960001680 ibuprofen Drugs 0.000 claims 1
- 229960000905 indomethacin Drugs 0.000 claims 1
- 230000004054 inflammatory process Effects 0.000 claims 1
- 239000007924 injection Substances 0.000 claims 1
- 238000002347 injection Methods 0.000 claims 1
- 229960004768 irinotecan Drugs 0.000 claims 1
- UWKQSNNFCGGAFS-XIFFEERXSA-N irinotecan Chemical compound C1=C2C(CC)=C3CN(C(C4=C([C@@](C(=O)OC4)(O)CC)C=4)=O)C=4C3=NC2=CC=C1OC(=O)N(CC1)CCC1N1CCCCC1 UWKQSNNFCGGAFS-XIFFEERXSA-N 0.000 claims 1
- DKYWVDODHFEZIM-UHFFFAOYSA-N ketoprofen Chemical compound OC(=O)C(C)C1=CC=CC(C(=O)C=2C=CC=CC=2)=C1 DKYWVDODHFEZIM-UHFFFAOYSA-N 0.000 claims 1
- 229960000991 ketoprofen Drugs 0.000 claims 1
- 229960004194 lidocaine Drugs 0.000 claims 1
- 239000003589 local anesthetic agent Substances 0.000 claims 1
- 229960005015 local anesthetics Drugs 0.000 claims 1
- 229960004857 mitomycin Drugs 0.000 claims 1
- 239000002088 nanocapsule Substances 0.000 claims 1
- 239000002077 nanosphere Substances 0.000 claims 1
- 229940053973 novocaine Drugs 0.000 claims 1
- 229920001542 oligosaccharide Polymers 0.000 claims 1
- 150000002482 oligosaccharides Chemical class 0.000 claims 1
- 229910052760 oxygen Inorganic materials 0.000 claims 1
- 239000002245 particle Substances 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 239000000825 pharmaceutical preparation Substances 0.000 claims 1
- 229940127557 pharmaceutical product Drugs 0.000 claims 1
- 230000000144 pharmacologic effect Effects 0.000 claims 1
- 229960001807 prilocaine Drugs 0.000 claims 1
- MVFGUOIZUNYYSO-UHFFFAOYSA-N prilocaine Chemical compound CCCNC(C)C(=O)NC1=CC=CC=C1C MVFGUOIZUNYYSO-UHFFFAOYSA-N 0.000 claims 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 1
- MFDFERRIHVXMIY-UHFFFAOYSA-N procaine Chemical compound CCN(CC)CCOC(=O)C1=CC=C(N)C=C1 MFDFERRIHVXMIY-UHFFFAOYSA-N 0.000 claims 1
- OLBCVFGFOZPWHH-UHFFFAOYSA-N propofol Chemical compound CC(C)C1=CC=CC(C(C)C)=C1O OLBCVFGFOZPWHH-UHFFFAOYSA-N 0.000 claims 1
- 229960004134 propofol Drugs 0.000 claims 1
- 230000009759 skin aging Effects 0.000 claims 1
- 210000004872 soft tissue Anatomy 0.000 claims 1
- 150000003431 steroids Chemical class 0.000 claims 1
- 125000001424 substituent group Chemical group 0.000 claims 1
- 229910052717 sulfur Inorganic materials 0.000 claims 1
- WINHZLLDWRZWRT-ATVHPVEESA-N sunitinib Chemical compound CCN(CC)CCNC(=O)C1=C(C)NC(\C=C/2C3=CC(F)=CC=C3NC\2=O)=C1C WINHZLLDWRZWRT-ATVHPVEESA-N 0.000 claims 1
- 229960001796 sunitinib Drugs 0.000 claims 1
- 208000011580 syndromic disease Diseases 0.000 claims 1
- SJMYWORNLPSJQO-UHFFFAOYSA-N tert-butyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OC(C)(C)C SJMYWORNLPSJQO-UHFFFAOYSA-N 0.000 claims 1
- ISXSCDLOGDJUNJ-UHFFFAOYSA-N tert-butyl prop-2-enoate Chemical compound CC(C)(C)OC(=O)C=C ISXSCDLOGDJUNJ-UHFFFAOYSA-N 0.000 claims 1
- 229960000707 tobramycin Drugs 0.000 claims 1
- NLVFBUXFDBBNBW-PBSUHMDJSA-N tobramycin Chemical compound N[C@@H]1C[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N NLVFBUXFDBBNBW-PBSUHMDJSA-N 0.000 claims 1
- 238000002054 transplantation Methods 0.000 claims 1
- 229960005294 triamcinolone Drugs 0.000 claims 1
- GFNANZIMVAIWHM-OBYCQNJPSA-N triamcinolone Chemical compound O=C1C=C[C@]2(C)[C@@]3(F)[C@@H](O)C[C@](C)([C@@]([C@H](O)C4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 GFNANZIMVAIWHM-OBYCQNJPSA-N 0.000 claims 1
- 230000029663 wound healing Effects 0.000 claims 1
- 229940072358 xylocaine Drugs 0.000 claims 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000013270 controlled release Methods 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 238000005538 encapsulation Methods 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161450725P | 2011-03-09 | 2011-03-09 | |
| EP11305254.2 | 2011-03-09 | ||
| US61/450,725 | 2011-03-09 | ||
| EP11305254 | 2011-03-09 | ||
| PCT/EP2012/054177 WO2012120138A1 (en) | 2011-03-09 | 2012-03-09 | Implantable swellable bio-resorbable polymer |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014511426A JP2014511426A (ja) | 2014-05-15 |
| JP2014511426A5 true JP2014511426A5 (https=) | 2016-01-21 |
| JP6078480B2 JP6078480B2 (ja) | 2017-02-08 |
Family
ID=44318232
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013557126A Active JP6078480B2 (ja) | 2011-03-09 | 2012-03-09 | 移植可能な膨潤性生体吸収性ポリマー |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US9320806B2 (https=) |
| EP (1) | EP2683750B1 (https=) |
| JP (1) | JP6078480B2 (https=) |
| AU (1) | AU2012224524B2 (https=) |
| ES (1) | ES2632769T3 (https=) |
| WO (1) | WO2012120138A1 (https=) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2027729A2 (en) | 2006-06-15 | 2009-02-25 | MicroVention, Inc. | Embolization device constructed from expansible polymer |
| WO2009086208A2 (en) | 2007-12-21 | 2009-07-09 | Microvention, Inc. | Hydrogel filaments for biomedical uses |
| US10028747B2 (en) | 2008-05-01 | 2018-07-24 | Aneuclose Llc | Coils with a series of proximally-and-distally-connected loops for occluding a cerebral aneurysm |
| US10716573B2 (en) | 2008-05-01 | 2020-07-21 | Aneuclose | Janjua aneurysm net with a resilient neck-bridging portion for occluding a cerebral aneurysm |
| US8757077B2 (en) | 2009-04-30 | 2014-06-24 | Technip France | Spar mooring line sharing method and system |
| EP2493367B1 (en) | 2009-10-26 | 2019-03-13 | Microvention, Inc. | Embolization device constructed from expansile polymer |
| US9358140B1 (en) | 2009-11-18 | 2016-06-07 | Aneuclose Llc | Stent with outer member to embolize an aneurysm |
| WO2012145431A2 (en) | 2011-04-18 | 2012-10-26 | Microvention, Inc. | Embolic devices |
| US9011884B2 (en) | 2012-04-18 | 2015-04-21 | Microvention, Inc. | Embolic devices |
| EP3046952B1 (en) | 2013-09-19 | 2021-05-12 | Terumo Corporation | Polymer particles |
| JP6641265B2 (ja) | 2013-09-19 | 2020-02-05 | マイクロベンション インコーポレイテッドＭｉｃｒｏｖｅｎｔｉｏｎ， Ｉｎｃ． | ポリマーフィルム |
| EP3065719A4 (en) | 2013-11-08 | 2017-08-09 | Terumo Corporation | Polymer particles |
| WO2015153996A1 (en) | 2014-04-03 | 2015-10-08 | Micro Vention, Inc. | Embolic devices |
| CN110433326A (zh) * | 2014-04-29 | 2019-11-12 | 微仙美国有限公司 | 包含活性剂的聚合物 |
| WO2015167751A1 (en) | 2014-04-29 | 2015-11-05 | Microvention, Inc. | Polymers |
| WO2016154592A1 (en) | 2015-03-26 | 2016-09-29 | Microvention, Inc. | Embiolic particles |
| WO2016201250A1 (en) | 2015-06-11 | 2016-12-15 | Microvention, Inc. | Expansile device for implantation |
| US10376469B2 (en) | 2016-02-17 | 2019-08-13 | Biosphere Medical, Inc. | Microspheres containing therapeutic agents and related methods of use |
| EP4279139A3 (en) | 2016-09-28 | 2024-01-24 | Terumo Corporation | Polymer particles |
| US11229604B2 (en) | 2017-08-16 | 2022-01-25 | Biosphere Medical, Inc. | Microspheres containing therapeutic agents and related methods of use |
| JP7665605B2 (ja) | 2019-10-07 | 2025-04-21 | ゲルベ | 非分解性の塞栓ミクロスフェア |
| KR20220079600A (ko) * | 2019-10-07 | 2022-06-13 | 게르브 | 비분해성 방사선 불투과성 색전술 미소구체 |
| CN114502603B (zh) * | 2019-10-11 | 2024-12-03 | 南洋理工大学 | 可降解聚合物材料 |
| CN113209370B (zh) * | 2020-01-21 | 2023-11-28 | 渼颜空间(河北)生物科技有限公司 | 可生物降解的注射填充物及其制备方法和其应用 |
| EP3936113A1 (en) * | 2020-07-07 | 2022-01-12 | Occlugel | Hydrophilic degradable microsphere for delivering travoprost |
| EP3936112A1 (en) * | 2020-07-07 | 2022-01-12 | Occlugel | Hydrophilic degradable microspheres for delivering buprenorphine |
| EP3936114A1 (en) * | 2020-07-07 | 2022-01-12 | Occlugel | Hydrophilic degradable microspheres for local delivering of glycopeptide antibiotics and polycationic peptide antibiotics |
| WO2022187725A1 (en) * | 2021-03-05 | 2022-09-09 | Sensorium Bio Inc. | Cell culture system and methods of using |
| DE102022200881A1 (de) | 2022-01-26 | 2023-07-27 | Henkel Ag & Co. Kgaa | Farbschützende Waschmittel |
| DE102022200882A1 (de) | 2022-01-26 | 2023-07-27 | Henkel Ag & Co. Kgaa | Polymere schmutzablösevermögende Wirkstoffe |
| EP4299080A1 (fr) | 2022-06-28 | 2024-01-03 | Guerbet | Monomère radio-opaque et microsphères d'embolisation le comprenant |
| CN114957588B (zh) * | 2022-06-28 | 2023-10-24 | 瑞聚再生(厦门)医学科技有限公司 | 一种可生物吸收神经支架及其制备方法 |
| JP2024142376A (ja) * | 2023-03-30 | 2024-10-11 | 国立大学法人福井大学 | 重合性組成物、共重合体、共重合体の製造方法及び共重合体製造用キット |
| CN116747349B (zh) * | 2023-06-01 | 2025-12-05 | 广州远想医学生物技术有限公司 | 一种注射用多孔微球、其制备方法和应用 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH10174711A (ja) * | 1996-09-23 | 1998-06-30 | Focal Inc | コンプライアントな組織シーラント |
| NZ502358A (en) * | 1997-07-18 | 2002-11-26 | Infimed Therapeutics Inc | Hydrogel composition comprising a biologically active substance combined with a macromer |
| WO2004087777A2 (en) | 2003-03-28 | 2004-10-14 | Carnegie Mellon University | Degradable polymers |
| JP2006232890A (ja) * | 2005-02-22 | 2006-09-07 | National Institute Of Advanced Industrial & Technology | 吸水性を有する生分解性架橋ポリマー及びその製造方法 |
| US20070031499A1 (en) * | 2005-07-28 | 2007-02-08 | Huh Kang M | Readily shapeable xerogels having controllably delayed swelling properties |
| KR20080067619A (ko) * | 2005-09-15 | 2008-07-21 | 유니버시티 오브 유타 리써치 파운데이션 | 고분자 조성물 및 이의 제조방법, 및 이의 용도 |
| JP4879554B2 (ja) * | 2005-10-21 | 2012-02-22 | 株式会社メニコン | ポストインプリント可能なヒドロゲル材料の製造方法 |
| WO2007072481A2 (en) | 2005-12-19 | 2007-06-28 | Capsutech Ltd. | Cyclodextrin-containing polymers and uses thereof |
| US20080199510A1 (en) * | 2007-02-20 | 2008-08-21 | Xtent, Inc. | Thermo-mechanically controlled implants and methods of use |
| US8277832B2 (en) | 2007-10-10 | 2012-10-02 | The University Of Kansas | Microsphere-based materials with predefined 3D spatial and temporal control of biomaterials, porosity and/or bioactive signals |
| WO2009132206A1 (en) * | 2008-04-25 | 2009-10-29 | Liquidia Technologies, Inc. | Compositions and methods for intracellular delivery and release of cargo |
| US9675417B2 (en) * | 2008-07-15 | 2017-06-13 | Koninklijke Philips N.V. | Safe ablation |
| EP2295480A1 (en) | 2009-09-10 | 2011-03-16 | Occlugel | Implantable bio-resorbable polymer |
-
2012
- 2012-03-09 AU AU2012224524A patent/AU2012224524B2/en active Active
- 2012-03-09 EP EP12707789.9A patent/EP2683750B1/en active Active
- 2012-03-09 ES ES12707789.9T patent/ES2632769T3/es active Active
- 2012-03-09 WO PCT/EP2012/054177 patent/WO2012120138A1/en not_active Ceased
- 2012-03-09 US US14/003,514 patent/US9320806B2/en active Active
- 2012-03-09 JP JP2013557126A patent/JP6078480B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014511426A5 (https=) | ||
| JP6078480B2 (ja) | 移植可能な膨潤性生体吸収性ポリマー | |
| JP2014511427A5 (https=) | ||
| KR101551681B1 (ko) | 변형된 히알루론산 폴리머 조성물 및 관련방법 | |
| CN102181060B (zh) | 聚乙烯醇-聚肽-聚乙二醇接枝共聚物及其制备方法 | |
| Badi et al. | PEG-based thermogels: Applicability in physiological media | |
| CN101684174B (zh) | 两亲性可生物降解聚酯梳型接枝共聚物及其温敏原位凝胶体系 | |
| WO2019095600A1 (zh) | 光偶合协同交联水凝胶材料的制备、原料、产品及应用 | |
| EP2475695B1 (en) | Implantable bio-resorbable polymer | |
| CN103224627B (zh) | 聚乳酸乙醇酸-聚肽-聚乙二醇二嵌段-接枝共聚物的制备方法 | |
| CN103748139B (zh) | 用于递送生物活性剂的包含生物可降解的聚酯酰胺共聚物的微米颗粒或纳米颗粒 | |
| CN102633959B (zh) | 一种具有pH响应性的梳状共聚物及其制法和应用 | |
| Tao et al. | Multi-stimuli responsive supramolecular hydrogels based on Fe 3+ and diblock copolymer micelle complexation | |
| CN102159251A (zh) | 制备控释系统的方法 | |
| CN102146200A (zh) | 一种基于化学交联凝胶颗粒的温敏性水凝胶及其制备方法 | |
| CN102352042A (zh) | 侧链功能化修饰的生物可降解型两亲性聚酯 | |
| CN101864069B (zh) | 一种生物降解性水凝胶及其合成方法 | |
| Wang et al. | Biodegradable branched polyesters poly (vinyl sulfonate-covinyl alcohol)-graft poly (D, L-lactic-coglycolic acid) as a negatively charged polyelectrolyte platform for drug delivery: synthesis and characterization | |
| CN114149596B (zh) | 相转变可调控的聚合物/锂藻土纳米粒子复合物热致水凝胶及其制备方法与应用 | |
| JP2012505305A5 (https=) | ||
| CN1839797A (zh) | 一种原位快速形成可注射超分子结构水凝胶的制备方法及其应用 | |
| US8796234B2 (en) | Crosslinking branched molecule through thiol-disulfide exchange to form hydrogel | |
| CN101007868A (zh) | 一种生物降解性纳米胶束控释制剂的制备方法 | |
| Bialik-Wąs et al. | Poly (acrylic acid-co-methyl methacrylate)/metronidazole systems: synthesis and complexation | |
| US20260042871A1 (en) | Cholesterol-modified hyaluronic acids |